News
QUE Oncology launches Phase II trials in the United States
QUE Oncology is beginning placebo-controlled Phase II trials of its drug Q-122 at US hospitals, testing it against hot flashes in breast cancer patients on endocrine therapy, with its CEO and a lead investigator quoted.